News: Brokerage

Hudson Valley iCampus featured in NYC Builds Bio webinar, ‘Gateways to the North’

Earl River, NY Hudson Valley iCampus, the 207-acre premier life sciences, biomed, manufacturing/warehouse and office campus was featured in “Gateways to the North,” a webinar in a series focusing on the growth of the life sciences industry in the New York region.

“We’re proud to be recognized as a major force in the New York region’s growing life sciences and biotech industry,” said Jamie Schwartz, president of Hudson Valley iCampus. “We have created an environment that is conducive to innovation and ingenuity on our campus, as well as opportunities for long-term growth.”

The 90-minute webinar, held July 26, presented an overview of life sciences and biotech developments in Rockland and Westchester counties, and the Bronx. The series is hosted by NYC Builds Bio, a New York-based organization that works to support life sciences and commercial real estate development through events, research, reports and educational programs.

Hudson Valley iCampus is a 2-million s/f multi-tenanted property and features a collaborative atmosphere of innovation fostered by leaders in their respective industries including Pfizer, Sanofi, Auro Vaccines, Lead Cyber Solutions and Urban Electric Power. The campus is known for historic, breakthrough vaccines developed on the grounds including vaccines for smallpox, typhoid and polio. Pfizer conducted research and development for the Covid-19 vaccine in its laboratory space in Pearl River, and it recently announced plans to invest $470 million to expand vaccine research there. Pfizer leases space at Hudson Valley iCampus and also owns property contiguous to the campus.

“There are many exciting changes underway at the Hudson Valley iCampus, a 25-building mixed-use campus on 207 acres strategically located in Rockland County,” said Sheena Gohil, executive managing director for the Tri-State team of Colliers, the exclusive leasing agent for the campus. “The campus offers amazing opportunities for companies in the life sciences and biomed sectors within the region.”

Gohil and Robert Lella, managing director of Colliers’ Tri-State team, were guests on the NYC Builds Bio event. They gave viewers an inside look at Hudson Valley iCampus via a virtual tour of the property, which includes laboratory, office, GMP manufacturing, warehouse, office space, and build-to-suit options to allow maximum flexibility for growth. They also highlighted unique features on the campus, including a 23-megawatt, state-of-the-art power plant that delivers cost effective, environmentally conscious and energy-efficient electricity, steam and chilled water to tenants. 

READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
A fresh start - by Shallini Mehra and Amit Doshi

A fresh start - by Shallini Mehra and Amit Doshi

For the past several years, the New York City multifamily housing market has been defined by disruption. The combined impact of the HSTPA rent laws and a sharply higher interest rate environment has fundamentally reduced
The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

July 1, 2025 is the deadline for US banks to begin to adopt Basel III banking standards and July 14, 2025 is the deadline for U.S. banks to adopt ISO 20022 messaging standards. Both will have a significant effect on the banking and commercial real estate (CRE) finance sectors.
Tri-state capital  migrates nationally amid  regulation pressure - by Reese Weaver

Tri-state capital migrates nationally amid regulation pressure - by Reese Weaver

New York tri-state multifamily investors are increasingly reallocating capital to less-regulated markets across the U.S. as rent control and legislative risk erode returns at home. With over 60% of New York City’s rental housing stock classified as rent-stabilized, the traditional value-add model — buying under-performing buildings,

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking